Prostate Cancer Consulting For Providers

Providers, are you seeking an AI-supported second opinion consultation for your patient’s diagnosis with Prostate Cancer?

Prostate cancer is one of the most common types of cancer among men with over 175,000 new cases diagnosed in the United States alone each year. As a healthcare provider, it can be challenging to navigate complex prostate cancer treatment options and provide the best care for your patients.

In recent years, there has been accelerating growth in the use of artificial intelligence (AI) technology to support clinical decision-making, including second opinion consultations for prostate cancer patients. With advancements in AI technology and increased availability of online platforms, providers now have access to a variety of resources that can aid in their patient’s diagnosis and treatment planning.

Precision Prostate Consulting’s AI-support second opinion consultation provides valuable insights and recommendations that aid in the early detection of prostate cancer. ProstatID analyzes patient MRI and medical history data, leading to earlier diagnoses, enhanced treatment planning and improved outcomes.

Furthermore, it is important to consider the time and resources required of the patient when considering the current pathway of prostate cancer detection and diagnosis. The current SOC recommends DRE and/or PSA blood tests when combined yields an effectiveness* of less than 60%. When presented with a positive, though possibly questionable indication, the subsequent  steps become even more demanding, for example, a referral for a 12-core TRUS biopsy which has been shown to have similar poor effectiveness but with much higher cost and potential negative side effects.

However, using a non-contrast MRI (bpMRI) with AI-augmented interpretation yields a far higher effectiveness (AUROC 93.6%) at detection while also indicating the extent and location of the disease in the organ, or it can provide the patient an equally reliable cancer free diagnosis.   No intrusive needles, no contrast, no side effects.

*see resources:  Area Under the ROC (sensitivity-specificity curve)